209 results on '"Zaorsky, Nicholas G."'
Search Results
2. PD57-04 MAJOR COMPLICATIONS AND ADVERSE EVENTS OF SPACEOAR HYDROGEL: AN ANALYSIS OF THE MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE
3. A population-based study of COVID-19 mortality risk in US cancer patients
4. Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy
5. Evaluating an academic radiation oncology position
6. Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer
7. Radiation Therapy for Renal Cell Carcinoma
8. Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial
9. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR
10. Real-World Data: Applications and Relevance to Cancer Clinical Trials
11. Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours
12. Do ask, do tell: improving health outcomes for sexual and gender minorities with cancer
13. Use of the Decipher genomic classifier among men with prostate cancer in the United States
14. Reirradiation with Stereotactic Body Radiotherapy for Primary or Secondary Lung Malignancies: Tumor Control Probability and Safety Analyses
15. Future trends in incidence and long-term survival of metastatic cancer in the United States
16. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
17. Unknown Causes of Death in Cancer Patients
18. Supplmentary Figures 1-3 from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
19. Supplementary Figure Legends from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
20. Supplmentary Figures 1-3 from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
21. Data from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
22. Data from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
23. Supplementary Figure Legends from ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK
24. Bone/Spine Cancers
25. General Principles of Radiation Oncology
26. Central Nervous System Cancers
27. Physics and Radiobiology
28. Lung Cancer
29. Pediatrics Cancers
30. Gynecologic Cancers
31. Genitourinary Cancers
32. Head and Neck Cancers
33. Gastrointestinal Cancers
34. Soft Tissue Cancers
35. Breast Cancer
36. Hematologic Cancers
37. Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer
38. An Introduction to Meta-Analysis
39. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients
40. Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX): A Meta-Analysis
41. Impact of Left-Digit Age Bias in the Treatment of Localized Prostate Cancer
42. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)
43. Development and dissemination of structured hashtags for radiation oncology: Two-Year trends
44. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States
45. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
46. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis
47. Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes
48. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium
49. Lutetium-177 DOTATATE: A Practical Review
50. Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.